CHLORMET TECHNOLOGIES INC Inactive Instrument
Chlormet Technologies Inc Stock Toronto S.E.
Equities
NWG
CA17026V1058
Healthcare Facilities & Services
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 0.67 0.92 | Sales 2023 | - | Capitalization | 179K 244K |
|---|---|---|---|---|---|
| Net income 2022 | -41M -55.94M | Net income 2023 | 17M 23.2M | EV / Sales 2022 | 27,812,179 x |
| Net Debt 2022 | 17.65M 24.09M | Net Debt 2023 | 411K 560K | EV / Sales 2023 | - |
| P/E ratio 2022 |
-0.01
x | P/E ratio 2023 |
0.01
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.18% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Nicholas Kuzyk
CEO | Chief Executive Officer | 45 | 22-09-06 |
| Director of Finance/CFO | - | 21-04-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 21-04-30 | |
Nicholas Kuzyk
CEO | Chief Executive Officer | 45 | 22-09-06 |
| Director/Board Member | - | - |
Digicann Ventures Inc., formerly Agra Ventures Ltd., is a Canada-based diversified company focused on the international cannabis industry. The Company is engaged in the cultivation, distribution and marketing of cannabis and cannabis-infused products around the world. It has a portfolio of licensed upstream, downstream, and product formulation assets. Its primary asset in Canada is Boundary Bay Cannabis, a cannabis greenhouse facility focused on the cultivation of high-potency cannabis. The Company's wholly owned subsidiary, Farmako GmbH (Farmako), is a distributor of medical cannabis. Farmako distributes the products in its network of German pharmacies. Its products have Farmako's branding. The products initially include high potency tetrahydrocannabinol (THC) flower and balanced THC and cannabidiol (CBD) flower. Farmako has product distribution operations in Germany and in the United Kingdom.
Calendar
2024-05-26
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 339M | |
| +48.56% | 299M | |
| +25.77% | 279M | |
| +51.16% | 206M | |
| +161.28% | 154M | |
| +48.02% | 132M | |
| -42.86% | 122M | |
| -40.82% | 119M | |
| +7.69% | 118M |
